4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-022705
President and Chief Executive sold 11,513 shares at an average $43.32 ($498,751)
- President and Chief Executive acquired 11,513 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2021-03-22 | Option exercise | +11,513 | $6.95 | $80,015 | 11,513 | D |
| Curran Terrie President and Chief Executive | 2021-03-22 | Sale | −10,373 | $43.24 | $448,495 | 1,140 | D |
| Curran Terrie President and Chief Executive | 2021-03-22 | Sale | −1,140 | $44.08 | $50,256 | 0 | D |
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2021-03-22 | Option exercise · Stock Option (Right to Buy) | −11,513 | 855,687 | D | ||
| Open-market sales · 11,513 sh · avg $43.32 · $498,751 | |||||||
Loading xslF345X03/doc4.xml…